---
title: AR Training Platform at Home
nct_id: NCT05627050
overall_status: UNKNOWN
phase: NA
sponsor: Chinese University of Hong Kong
study_type: INTERVENTIONAL
primary_condition: Stroke
countries: Hong Kong
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT05627050.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT05627050"
ct_last_update_post_date: 2022-11-25
last_seen_at: "2026-05-12T06:04:23.913Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# AR Training Platform at Home

**Official Title:** Online AR Training Platform for the Elderly and Persons With Chronic Diseases at Home

**NCT ID:** [NCT05627050](https://clinicaltrials.gov/study/NCT05627050)

## Key Facts

- **Status:** UNKNOWN
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 600
- **Lead Sponsor:** Chinese University of Hong Kong
- **Conditions:** Stroke, Chronic Disease
- **Start Date:** 2021-01-13
- **Completion Date:** 2024-12
- **CT.gov Last Update:** 2022-11-25

## Brief Summary

Video Communications, like ZOOM, have been widely used in the time of this epidemic. But how about to design an AR / VR communication system with coaching from clinician to facilitate training at home in this time of epidemic. Vulnerable individuals at home can interact with the training platform and his/her clinician can provide online training progamme with guidance.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

1. age \>=65 years old or suffering from chronic disease;
2. sufficient cognition to follow simple instructions as well as understand the content and purpose of the study MoCA\> 21); and
3. Home setting: TV with HDMI input, internet access, and a distance of 1.5m away from TV.

Exclusion Criteria:

1. Any additional medical or psychological condition that would affect their ability to comply with the study protocol, e.g., a significant orthopaedic or chronic pain condition, major post-stroke depression, epilepsy, artificial cardiac pacemaker / joint;
2. Severe shoulder or arm contracture/pain;
3. Severe knee or hip contracture/pain;
4. Pregnant women
```

## Arms

- **AR Training System** (EXPERIMENTAL) — The subjects follow the daily rehabilitation training program designed by clinical and healthcare team. The system will monitor their movement and provide feedbacks to the users. The clinicians/healthcare workers can provide feedbacks and guidance to correct their movements and postures.

## Interventions

- **An Online Augmented Reality (AR) Training Platform** (DEVICE) — The hardware system is based on camera depth sensor and combined with 3D human tracking technology and intelligent technology, to monitor, correct and record the user's whole body movements in real-time, and the users can follow the training program.

## Primary Outcomes

- **Fugl-Meyer Assessment** _(time frame: 6-month after the first training)_ — Fugl-Meyer Assessment for Upper-Extremity the maximum score is 66, divided into 33 items in the form of a 3-point scale (0-2), 0 is cannot perform and 2 performs fully.

Fugl-Meyer Assessment for Lower-Extremity consists of 34-level cumulative scoring system to examine lower-limb functions of hemiplegic stroke patients quantitatively through a set of lower-limb movement tasks in reflex, flexor/extensor synergy, volitional movement, coordination and speed (Fugl-Meyer, et al., 1975).

## Secondary Outcomes

- **The 12-item Short Form Survey** _(time frame: 6-month after the first training)_
- **Barthel Index** _(time frame: 6-month after the first training)_
- **Berg Balance Scale** _(time frame: 6-month after the first training)_
- **Modified Ashworth Scale** _(time frame: 6-month after the first training)_
- **Functional Ambulation Category Test** _(time frame: 6-month after the first training)_

## Locations (1)

- Department of Biomedical Engineering, The Chinese University of Hong Kong, Hong Kong, Hong Kong — _RECRUITING_

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.department of biomedical engineering, the chinese university of hong kong|hong kong||hong kong` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT05627050.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT05627050*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*